4//SEC Filing
Gilman Sydney A. 4
Accession 0001235802-21-000094
CIK 0001401040other
Filed
Jul 28, 8:00 PM ET
Accepted
Jul 29, 9:18 PM ET
Size
5.9 KB
Accession
0001235802-21-000094
Insider Transaction Report
Form 4
Gilman Sydney A.
VP, Regulatory Affairs
Transactions
- Award
Stock Option (right to buy)
2021-07-28+25,000→ 25,000 totalExercise: $5.00Exp: 2031-07-27→ Common Shares (25,000 underlying)
Holdings
- 0
Voting Common Shares, no par value per share
Footnotes (1)
- [F1]Vests in sixteen nearly equal quarterly installments over four years.
Documents
Issuer
DiaMedica Therapeutics Inc.
CIK 0001401040
Entity typeother
Related Parties
1- filerCIK 0001793016
Filing Metadata
- Form type
- 4
- Filed
- Jul 28, 8:00 PM ET
- Accepted
- Jul 29, 9:18 PM ET
- Size
- 5.9 KB